Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Aug 14;8(8):e3015. doi: 10.1371/journal.pntd.0003015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 Gao et al

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.

PMC Copyright notice

The thumbnail in the upper right corner is cited from reference [1]. The bar indicates JE case numbers. The JE pandemic in China peaked during 1965–1977. JE incidence decreased significantly after the local government covered a large proportion of immunization costs. In 2008, the JE vaccine was included in the EPI by the central government, and JE immunization became free throughout China. Subsequently, JE has been controlled and the incidence remains at a low level. The arrow indicates the introduction of the P3 inactivated JE vaccine in 1968. The arrow indicates the point at which the SA 14-14-2 live-attenuated JE vaccine was licensed for use in China in 1988.

Inline graphic — The thumbnail in the upper right corner is cited from reference [1]. The bar indicates JE case numbers. The JE pandemic in China peaked during 1965–1977. JE incidence decreased significantly after the local government covered a large proportion of immunization costs. In 2008, the JE vaccine was included in the EPI by the central government, and JE immunization became free throughout China. Subsequently, JE has been controlled and the incidence remains at a low level. The arrow indicates the introduction of the P3 inactivated JE vaccine in 1968. The arrow indicates the point at which the SA 14-14-2 live-attenuated JE vaccine was licensed for use in China in 1988.